In order to clarify the potential mechanism behind the knockdown of MYOF suppressing the malignant phenotype, we investigated whether MYOF knockdown can influence EGFR or EPHA2 activity in NPC cells. The gene discussed is EPHA2; the disease is nasopharyngeal carcinoma.